News

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
Precise Volume Measurement Prior to Discharge Identifies Mortality RiskOak Ridge, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation ...
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
Advanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Daxor ...
Mena FN8d
New Research At ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
through BVA showed markedly improved one-year survival rates In a Kaplan-Meier survival study, a hazard ratio, the risk of the event (in this case, death), is 2.61 times higher in the control ...